India Unveils First Indigenous H5N1 Bird Flu Vaccine for Chickens
Union Agriculture Minister Shivraj Singh Chouhan has unveiled India’s first indigenous H5N1 bird flu vaccine for chickens, developed by ICAR-NIHSAD and priced at ₹1-2 per dose.
- India unveiled its first indigenous H5N1 bird flu vaccine for chickens, priced at ₹1-2 per dose.
- The vaccine was developed by scientists at ICAR-NIHSAD in Bhopal under stringent biosafety protocols.
- Union Agriculture Minister Shivraj Singh Chouhan announced a new ₹300 crore state-of-the-art laboratory in Bhopal.

India has introduced its first indigenous vaccine targeting the H5N1 strain of avian influenza in chickens, with Union Agriculture and Farmers’ Welfare Minister Shivraj Singh Chouhan dedicating the immunization to the nation. Developed by scientists at the Indian Council of Agricultural Research’s National Institute of High Security Animal Diseases in Bhopal, the vaccine is priced between ₹1 and ₹2 per dose. Government officials stated it is the world’s first vaccine against this specific bird flu variant.
Research, Biosafety Protocols, and Economic Impact
The research team operated under strict biosafety measures that required daily sanitization, substantial water usage for bathing, and restrictions against keeping pets at home. Chouhan noted that animal husbandry contributes 14% to India’s gross domestic product, while the poultry sector accounts for an additional 1%. Disease outbreaks have historically inflicted severe financial damage, including ₹22,000 crore annually from foot-and-mouth disease, ₹20,000 crore from lumpy skin disease, ₹9,212 crore from brucellosis, and ₹4,683 crore from peste des petits ruminants, totaling approximately ₹56,000 crore in economic burdens.
Historical Context of Bird Flu and New Infrastructure
India's initial recorded bird flu outbreak occurred in 2006 in Navapur, Maharashtra, causing the death of roughly one million chickens alongside extensive culling. The country has since experienced more than 500 outbreaks, resulting in the loss of about nine lakh chickens in 2021 and an additional two lakh birds. In response to these ongoing biosecurity risks and potential transmission to mammals and humans, Chouhan announced plans to construct a new state-of-the-art animal disease research laboratory in Bhopal with an estimated budget of ₹300 crore.
- The H5N1 vaccine is priced at ₹1-2 per dose and developed by ICAR-NIHSAD scientists.
- India has recorded over 500 bird flu outbreaks since the first incident in Navapur in 2006.
- A new state-of-the-art laboratory is planned in Bhopal at an estimated cost of ₹300 crore.
Spotted an error? · Our editorial policy
UP NEXTBJP MP Nishikant Dubey Alleges Sonia Gandhi Held Major Stake in Early Maruti VentureOther angles · #Bhopal
Timeline →More from India

Delhi Court Sentences Man to Life Imprisonment for Strangling Wife

Prime Minister Narendra Modi Visits IIT Kharagpur for Platinum Jubilee Celebrations

Ladakh Holds First Local Body Elections Since 2019 Reorganization
